WT
BIVV

Whittier Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Whittier Trust’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-623
Closed -$34K – 1373
2017
Q4 		$34K Sell
623
-94
-13% -$5.14K ﹤0.01% 827
2017
Q3 		$41K Sell
717
-205
-22% -$12K ﹤0.01% 782
2017
Q2 		$56K Sell
922
-80
-8% -$4.56K ﹤0.01% 683
2017
Q1 		$54K Buy
+1,002
New +$49.4K ﹤0.01% 700

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Whittier Trust's BIVV Position: Q1 2018 in Review

Whittier Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 623 shares — an estimated $34K sold.

Whittier Trust first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $56K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Whittier Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Whittier Trust sold 623 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $34K.
  • Whittier Trust first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Whittier Trust's Bioverativ Inc. Common Stock position peaked at $56K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Whittier Trust's 13F filing for Q1 2018, filed 1 May 2018.